Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Biography

Meet the Editorial Board Member

Author(s): Nunzio Pomara

Volume 17, Issue 4, 2022

Published on: 21 July, 2022

Page: [221 - 221] Pages: 1

DOI: 10.2174/157488551704220721123608

Next »
[1]
Tagliarini C, Carbone MG, Pagni G, Marazziti D, Pomara N. Is There a Relationship between Morphological and Functional Plate-let Changes and Depressive Disorder? CNS Spectr 2022; 27(2): 157-90.
[http://dx.doi.org/10.1017/S1092852920001959]
[2]
Teipel SJ, Dyrba M, Ballarini T, et al. Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Re-sponse in the Alzheimer’s Disease Spectrum. J Alzheimers Dis 2022; 85(3): 1267-82.
[http://dx.doi.org/10.3233/JAD-215196]
[3]
Shen X-N, Huang Y-Y, Chen S-D, et al. Alzheimer’s Disease Neuroimaging Initiative. Plasma Phos-phorylated-Tau181 as a Predictive Biomarker for Alzheimer’s Amyloid, Tau and FDG PET Status. Transl Psychiatry 2021; 11(1): 585.
[http://dx.doi.org/10.1038/s41398-021-01709-9]
[4]
Chen S-D, Lu J-Y, Li H-Q, et al. Alzheimer’s Disease Neuroim-aging Initiative. Staging Tau Pathology with Tau PET in Alzheimer’s Disease: A Longitudinal Study. Transl Psychiatry 2021; 11(1): 483.
[http://dx.doi.org/10.1038/s41398-021-01602-5]
[5]
Hu WT, Ozturk T, Kollhoff A, Wharton W, Christina Howell J. Alzheimer’s Disease Neuroimaging Initiative. Higher CSF STNFR1-Related Proteins Associate with Better Prognosis in Very Early Alzheimer’s Disease. Nat Commun 2021; 12(1): 4001.
[http://dx.doi.org/10.1038/s41467-021-24220-7]

© 2024 Bentham Science Publishers | Privacy Policy